awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41107790-40CB3AFE-DB51-4503-931F-4EDC8BD802F8
Q41107790-40CB3AFE-DB51-4503-931F-4EDC8BD802F8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41107790-40CB3AFE-DB51-4503-931F-4EDC8BD802F8
EGFR or PD-L1 decision for first line therapy in a case series of EGFR positive and PD-L1 >50.
P2860
Q41107790-40CB3AFE-DB51-4503-931F-4EDC8BD802F8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41107790-40CB3AFE-DB51-4503-931F-4EDC8BD802F8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e61eed06456cd1acb57e56b6717afe6fb1adaca3
P2860
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.